# India Animal Vaccines Market

> India Animal Vaccines Market Research Report By Technology (Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, DNA Vaccines, mRNA Vaccines), By Animal Type (Pets, Livestock, Poultry, Wildlife, Aquaculture), By Route of Administration (Injectable, Oral, Intranasal, Topical) and By Distribution Channel (Veterinary Clinics, Retail Pharmacies, Online Pharmacies, Animal Hospitals) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.62%
- **2024:** $ 575.75 Million
- **2025:** $ 619.62 Million
- **2035:** $ 1,291.45 Million
- **Key Players:** Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Ceva Santé Animale (FR), Heska Corporation (US), Vetoquinol (FR)

**Report ID:** MRFR/Pharma/47440-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-animal-vaccines-market-49187

---

## Market Summary

## **India Animal Vaccines Market Overview**

As per MRFR analysis, the India Animal Vaccines Market Size was estimated at 238 (USD Million) in 2023.The India Animal Vaccines Market is expected to grow from 248.4(USD Million) in 2024 to 496.8 (USD Million) by 2035. The India Animal Vaccines Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).

**Key India Animal Vaccines Market Trends Highlighted**

Various elements are driving notable expansion in the India Animal Vaccines Market. Increasing knowledge among livestock producers about the need for animal health and preventative actions is one of the main market drivers as it helps to guarantee food safety and security. Especially with the drive toward improving the dairy and poultry industries, the government of India has been aggressively supporting vaccination campaigns for animals to fight illnesses that can affect livestock production. High-quality animal products are also in more customer demand, which drives farmers to use vaccines to enhance the general health of their animals.

The growing livestock sector offers great possibilities in the India Animal Vaccines Market. Government efforts to strengthen animal husbandry by means of research and development of novel vaccinations help to provide a good environment for businesses to manufacture and introduce successful goods. Furthermore, as urbanization develops, there is more possibility for companion animal immunizations, a category that has grown in recent years. The importance of zoonotic diseases and their effect on public health underlines even more the necessity of strong vaccination policies, which pave the way for further government and private sector cooperation.

Recent developments in the India Animal Vaccines Market reveal a move toward more sophisticated and efficient vaccine formulations, including recombinant vaccines and thermostable choices that can preserve effectiveness under various environmental circumstances. Vaccine research is being driven by biotechnology, which is opening the door for creative answers addressing both conventional and new illnesses. Furthermore, the increased usage of digital technology in veterinary healthcare is providing improved vaccine monitoring and management, ensuring that vaccination regimens are followed and helping farmers maximize their livestock health practices.

The India Animal Vaccines Market is changing with a sharp eye on creativity, health awareness, and improved stakeholder cooperation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**India Animal Vaccines Market Drivers**

**Rising Livestock Population in India**

The India Animal Vaccines Market Industry is experiencing significant growth due to the increasing livestock population. According to the 20th Livestock Census conducted by the Government of India, the country's livestock population reached over 535 million in 2019, representing a 4.6% increase since the previous census. This growing population creates a rising demand for animal vaccines to ensure the health and productivity of these animals. 

Organizations such as the Indian Council of Agricultural Research (ICAR) are emphasizing the need for increased vaccination programs to control diseases among livestock.With diseases such as Foot-and-Mouth Disease and Brucellosis posing risks to animal health and agricultural productivity, the expansion of vaccination initiatives is essential, thereby propelling the India Animal Vaccines Market Industry.

**Government Initiatives for Animal Health**

The Indian government has prioritized animal health and disease management, which is a significant driver for the India Animal Vaccines Market Industry. Programs like the National Animal Disease Control Programme aim to vaccinate a significant portion of the livestock population against major diseases, targeting to immunize over 500 million livestock units. The allocation of substantial financial resources for vaccination campaigns and veterinary services enhances the development and availability of animal vaccines, resulting in increased market growth.

Institutions such as the Department of Animal Husbandry and Dairying have been pivotal in promoting vaccination awareness and campaigns across rural areas, strengthening the overall animal health infrastructure.

**Technological Advancements in Vaccine Development**

Technological innovations in vaccine development are crucial in the India Animal Vaccines Market Industry's growth trajectory. The development of advanced vaccines, such as subunit vaccines and mRNA vaccines, promises effective disease control and improved safety for animals. According to the Ministry of Science and Technology, several laboratories and research institutions are focused on Research and Development (R&D) to develop next-generation vaccines that are more effective and easier to administer.

The introduction of these new technologies positions the Indian veterinary market to address both current and emerging health challenges efficiently, driving substantial growth in the animal vaccines sector.

**India Animal Vaccines Market Segment Insights**

**Animal Vaccines Market Technology Insights**

The India Animal Vaccines Market, particularly within the Technology segment, is experiencing significant advancements driven by various vaccine types that cater to a wide range of animal health needs. Inactivated Vaccines are recognized for their robustness, often considered the gold standard for immune response in animals, making them a popular choice among veterinarians and livestock owners.

Meanwhile, Attenuated Vaccines, known for activating a strong and quick immune response, hold substantial importance in preventing contagious diseases among livestock, particularly in densely populated animal farming regions in India.Subunit Vaccines, which use only specific parts of the pathogen, are gaining traction due to their safety profile and the potential for targeted immunity, thus minimizing unwanted reactions. 

This technology is especially relevant in urban and semi-urban settings where pet ownership is surging. On the other hand, DNA Vaccines are emerging as a cutting-edge alternative, offering benefits such as stability and ease of production, which resonates well with the growing demand for rapid vaccine development in India as zoonotic diseases become more prevalent.mRNA Vaccines, although traditionally associated with human health, are beginning to capture interest in the animal health sector as advancements in biotech enable their development for veterinary applications.

With the rise of genomic technology, these types of vaccines present an exciting opportunity to mitigate disease threats and improve animal health outcomes by harnessing the body's natural immune response. The overall dynamics of the Technology segment within the India Animal Vaccines Market indicate a move towards innovation and modernization, driven by the increasing need for effective disease management strategies in both livestock and companion animals. 

Furthermore, government initiatives in India focusing on strengthening the agricultural sector, alongside the growing population and increased meat consumption, establish a favorable environment for the evolution of these technologies. This sustained focus on animal health has spurred Research and Development efforts, particularly in vaccine technology, thereby enhancing the capacity for tackling animal diseases in a more efficient manner. Overall, the Technology segment within the India Animal Vaccines Market showcases a landscape ripe with potential for growth, driven by scientific progress and the pressing need for enhancing animal health.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Animal Vaccines Market Animal Type Insights**

The India Animal Vaccines Market segmentation based on Animal Type shows significant diversity among its categories, each contributing uniquely to the overall landscape. Pets, including dogs and cats, are gaining popularity in urban areas, driving the demand for innovative vaccines to protect against diseases. Livestock, which comprises cattle, sheep, and goats, represents a substantial portion of the market due to the country’s reliance on agriculture and dairy production.

Consequently, there is a continuous need for effective vaccination to enhance productivity and safeguard farmers' livelihoods.The poultry sector remains vital, as India ranks among the largest producers of eggs and chicken meat, warranting robust vaccination programs to combat prevalent diseases. 

Wildlife vaccines are becoming increasingly crucial, especially in protecting endangered species and containing zoonotic diseases that affect human populations. Aquaculture is witnessing growth as well, given the rising demand for fish and seafood, necessitating vaccines to ensure the health of aquatic species. Overall, each category under the Animal Type segment of the India Animal Vaccines Market reflects the interplay of economic factors and public health considerations, highlighting the market's potential trajectory and growth opportunities.

**Animal Vaccines Market Route of Administration Insights**

The India Animal Vaccines Market, particularly within the Route of Administration segment, showcases a diverse range of delivery methods critical for ensuring effective immunization across various animal species. Injectable vaccines continue to lead in popularity due to their reliability and fast-acting responses, making them essential for rapid disease control. Oral vaccines play a significant role in increasing compliance among animal owners, particularly in livestock, as they are easy to administer. Intranasal vaccines are gaining traction, particularly for respiratory illnesses, due to their non-invasive nature and ability to elicit strong mucosal immunity.

Meanwhile, topical applications are becoming increasingly relevant, especially for certain types of diseases that require localized treatment. This diversity in routes supports the unique needs of the veterinary field in India, addressing factors such as ease of use, target animal species, and specific disease challenges prevalent in the region. As the veterinary landscape evolves, the demand for varied administration methods reflects the ongoing commitment to improving animal health and productivity, aligning with the national focus on agricultural stability and food security.

**Animal Vaccines Market Distribution Channel Insights**

The Distribution Channel segment of the India Animal Vaccines Market plays a crucial role in ensuring the availability and accessibility of vaccines across various platforms. Veterinary Clinics serve as primary points for the administration and recommendation of vaccines, underscoring their significance in disease prevention among domestic animals. Retail Pharmacies offer convenience for pet owners seeking over-the-counter vaccination solutions, contributing to the market's growth by increasing consumer reach.

Meanwhile, Online Pharmacies have gained traction, particularly amidst the digital shift in healthcare, allowing consumers to easily procure vaccines without geographical constraints.Animal Hospitals, equipped with veterinary specialists, are essential for administering complex vaccinations and managing animal health comprehensively. 

This diversified distribution approach is vital for addressing varying consumer preferences and enhancing the overall efficiency of vaccination programs in India. The market dynamics reflect a trend toward holistic access to vaccines, ensuring that critical immunizations are delivered effectively to safeguard animal health and support livestock productivity in a growing agricultural economy. Moreover, the rising awareness of animal health and welfare in India fuels the demand across all distribution avenues, highlighting the importance of an integrated and responsive distribution network in the animal healthcare ecosystem.

**India Animal Vaccines Market Key Players and Competitive Insights**

The competitive landscape of the India Animal Vaccines Market is characterized by a mix of domestic and international players striving to gain a foothold in a region witnessing substantial growth due to increasing livestock populations and the rising awareness of disease management among animal husbandry professionals. As this market expands, companies focus on developing innovative and effective vaccine solutions to address various infectious diseases that affect livestock and companion animals alike.

The increasing demand for protein-rich food and the rising incidence of zoonotic diseases are propelling market dynamics, thus encouraging manufacturers to enhance their production capabilities and improve their distribution networks. 

Collaboration with veterinary practitioners and educational institutions further strengthens their market positioning as they push for advancements in preventive healthcare for animals.Equine Biotech has established a significant presence in the India Animal Vaccines Market with an emphasis on high-quality vaccines and innovative health solutions for equine and livestock. The company capitalizes on an extensive research and development framework that allows it to stay ahead in the competitive race by introducing advanced vaccine formulations tailored specifically for Indian livestock needs.

The strengths of Equine Biotech lie in its dedicated customer support, substantial investment in local manufacturing, and robust distribution channels that cater to rural and urban veterinary needs. By focusing on building long-term relationships with veterinarians and livestock farmers, Equine Biotech effectively enhances its brand presence and market share within the region.

Vetoquinol, a renowned player in the global animal health sector, is making significant strides in the India Animal Vaccines Market through its strong portfolio of vaccines and treatments. The company's key offerings include vaccines for various diseases affecting both large and small animals, emphasizing efficacy and safety. With a well-established market presence in India, Vetoquinol takes advantage of strict regulatory compliance and partnerships with local stakeholders to ensure its products meet the needs of Indian veterinarians and farmers. Strengths include innovative product development, a wide range of veterinary pharmaceuticals, and strategic mergers that have bolstered their market position.

Their commitment to research and development is evident as they consistently invest in formulating new solutions that address emerging health challenges within the Indian animal population.

**Key Companies in the India Animal Vaccines Market Include:**

- Equine Biotech
- Vetoquinol
- Aventis Pharma
- India Immunologicals
- Virbac
- Zoetis
- Merck Animal Health
- Elanco Animal Health
- Boehringer Ingelheim
- Hester Biosciences
- Nectar Life Sciences
- Ind Swift Laboratories
- Prawn Biotechnology
- Biovet
- Cadila Healthcare

**India Animal Vaccines Market Industry Developments**

The India Animal Vaccines Market has witnessed significant developments recently, notably with an increasing focus on disease prevention and control among livestock, leading to strong demand for effective vaccines. Companies such as Zoetis, Merck Animal Health, and Hester Biosciences are actively working on innovative vaccine solutions to address the surge in zoonotic diseases. In September 2023, Boehringer Ingelheim announced advancements in their veterinary vaccines that bolster protection against multiple pathogens affecting cattle and poultry, further enhancing their market presence. 

Additionally, in July 2023, Vetoquinol reported new partnerships with local veterinary networks to expand their distribution channels across India, influencing growth rates in the sector. In terms of mergers and acquisitions, India Immunologicals revealed plans for acquiring a smaller firm in August 2023 aimed at enhancing their production capabilities, bolstering their position in the vaccine market. The market is projected to experience significant growth, with a reported valuation expected to reach USD 2 billion by 2025, driven by an increase in livestock populations and heightened awareness regarding animal health in the country.

**India Animal Vaccines Market Segmentation Insights**

- **Animal Vaccines Market Technology Outlook** - Inactivated Vaccines - Attenuated Vaccines - Subunit Vaccines - DNA Vaccines - mRNA Vaccines
- **Animal Vaccines Market Animal Type Outlook** - Pets - Livestock - Poultry - Wildlife - Aquaculture
- **Animal Vaccines Market Route of Administration Outlook** - Injectable - Oral - Intranasal - Topical
- **Animal Vaccines Market Distribution Channel Outlook** - Veterinary Clinics - Retail Pharmacies - Online Pharmacies - Animal Hospitals

## Market Drivers

### Growing Pet Ownership Trends

The rising trend of pet ownership in India is significantly influencing the market. As more households adopt pets, the demand for veterinary services, including vaccinations, is on the rise. Reports suggest that the pet care market in India is projected to reach approximately $1.5 billion by 2025, indicating a robust growth trajectory. This trend is likely to drive the animal vaccines market as pet owners become more aware of the importance of preventive healthcare for their animals. Consequently, the market is expected to expand in response to the increasing need for vaccinations among companion animals.

### Government Initiatives and Support

Government initiatives play a crucial role in shaping the animal vaccines market in India. Various programs aimed at promoting vaccination among livestock and pets are being implemented, which may lead to increased adoption of vaccines. The Indian government has launched schemes to provide subsidized vaccines to farmers, thereby reducing the financial burden associated with vaccination. This support is likely to stimulate market growth, as it encourages farmers to vaccinate their animals, ultimately leading to healthier livestock and improved productivity. The animal vaccines market is poised to benefit from these proactive measures.

### Rising Incidence of Animal Diseases

The increasing incidence of animal diseases in India is a significant driver for the animal vaccines market. Outbreaks of diseases such as Foot and Mouth Disease (FMD) and Canine Parvovirus have raised concerns among farmers and pet owners alike. The economic impact of these diseases can be substantial, leading to losses in livestock productivity and increased veterinary costs. As a result, there is a heightened urgency to vaccinate animals to prevent such outbreaks. The animal vaccines market is likely to see a surge in demand as stakeholders seek effective solutions to combat these health threats.

### Increasing Awareness of Animal Health

The growing awareness regarding animal health and welfare is a pivotal driver for the animal vaccines market. In India, farmers and pet owners are increasingly recognizing the importance of vaccination in preventing diseases. This awareness is likely to enhance the demand for vaccines, as it correlates with improved livestock productivity and companion animal health. Reports indicate that the livestock sector contributes approximately 4.6% to India's GDP, underscoring the economic significance of animal health. Consequently, the animal vaccines market is expected to expand as stakeholders prioritize vaccination to mitigate disease outbreaks and enhance overall animal welfare.

### Technological Advancements in Vaccine Development

Technological advancements in vaccine development are transforming the landscape of the animal vaccines market. Innovations such as recombinant vaccines and mRNA technology are being explored to enhance vaccine efficacy and safety. In India, research institutions and pharmaceutical companies are increasingly investing in R&D to develop next-generation vaccines tailored to local disease challenges. This focus on innovation is expected to drive market growth, as more effective vaccines become available, addressing the specific needs of the Indian livestock and companion animal sectors. The animal vaccines market stands to gain from these advancements.

## Future Outlook

The [Animal Vaccines Market](https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184) is projected to grow at a 7.62% CAGR from 2025 to 2035, driven by increasing livestock production, rising pet ownership, and advancements in vaccine technology.

**New opportunities:**

- Development of personalized vaccines for high-value livestock species. Expansion of mobile vaccination units in rural areas. Investment in digital platforms for vaccine tracking and management.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand.

## Segment Insights

### By Technology: Inactivated Vaccines (Largest) vs. DNA Vaccines (Fastest-Growing)

In the India animal vaccines market, inactivated vaccines hold the largest share due to their established efficacy and widespread acceptance among veterinarians and animal health professionals. These vaccines offer significant protection against various diseases, leading to a strong preference among livestock and pet owners. In contrast, DNA vaccines, while currently smaller in market share, are rapidly gaining traction as a result of their innovative approach and effectiveness against specific pathogens. The growth trends in this segment are marked by an increasing focus on research and development, leading to the introduction of novel vaccine formats. The rising awareness of zoonotic diseases and the need for effective vaccination programs also drive demand. Furthermore, regulatory support and the growing investment in biotechnological advancements in India enhance the potential for DNA vaccines to emerge as a significant player, establishing a new paradigm in animal health vaccination strategies.

Technology: Inactivated Vaccines (Dominant) vs. DNA Vaccines (Emerging)

Inactivated vaccines are currently the dominant technology in the India animal vaccines market, characterized by their safety, stability, and proven track record in preventing diseases in animals. These vaccines are formulated using killed pathogens, ensuring that they do not cause the disease but still elicit a robust immune response. Conversely, DNA vaccines represent an emerging technology that offers several advantages, including enhanced efficacy and the ability to target specific pathogens with precision. Their mechanism involves introducing recombinant DNA into host cells, allowing for a strong and long-lasting immune response. This innovative approach to vaccination is gaining support from veterinarians and researchers looking for efficient solutions to address animal health challenges.

### By Animal Type: Poultry (Largest) vs. Pets (Fastest-Growing)

In the India animal vaccines market, the distribution of market share among various animal types reveals Poultry as the largest segment, driven by the intensive farming practices prevalent in the region. Livestock follows closely, with strong demand for vaccines essential for maintaining health and productivity. Pets represent a smaller but rapidly expanding segment, reflecting the increasing trend towards pet ownership and a growing awareness of animal health and welfare. Growth trends indicate that while Poultry remains dominant due to its established market presence, the Pets segment is experiencing the fastest growth. This surge is supported by greater disposable incomes, urbanization, and increased pet humanization among Indian households. Furthermore, the awareness of zoonotic diseases has heightened the focus on comprehensive vaccination programs for both livestock and pets, driving overall market growth.

Poultry (Dominant) vs. Pets (Emerging)

Poultry vaccines dominate the India animal vaccines market, supported by widespread consumption and the necessity of disease prevention in large-scale poultry operations. The emphasis on biosecurity and high production efficiency further cements Poultry's leading position. In contrast, the Pets segment, classified as emerging, is gaining traction as pet ownership soars and more households invest in pet health care. The rise of online veterinary services and pet insurance is also contributing to this growth, making it easier for pet owners to access essential vaccines. Both segments reflect the evolving dynamics of animal husbandry in India, with Poultry focusing on mass production and Pets tailoring to individual health and wellness.

### By Route of Administration: Injectable (Largest) vs. Oral (Fastest-Growing)

In the India animal vaccines market, the route of administration segment is characterized by a diverse range of options including injectable, oral, intranasal, and topical methods. Among these, injectable vaccines hold the largest market share, attributed to their widespread acceptance and efficacy in delivering immunization in various animal species. Conversely, oral vaccines are gaining traction, rapidly increasing their share as they offer ease of administration and improved compliance among pet owners and livestock handlers. Growth trends within this segment are largely driven by advancements in veterinary medicine and an increasing emphasis on animal health. Injectable vaccines continue to dominate due to their reliability and established protocols. However, the rising popularity of oral vaccines reflects a shift towards more convenient and less invasive methods, creating ample opportunities for innovation and investment in the developing landscape of animal healthcare in India.

Injectable (Dominant) vs. Oral (Emerging)

Injectable vaccines are recognized as the dominant route of administration in the India animal vaccines market, offering high efficacy and well-documented delivery methods. They are commonly used for a variety of diseases, providing quick immune responses. On the other hand, oral vaccines are emerging as a viable alternative, particularly for their user-friendly nature and the ability to administer them without the need for specialized equipment. This emerging segment is expected to capture a growing share of the market, bolstered by ongoing research to enhance their stability and effectiveness, reflecting a significant shift towards accessible vaccination strategies for animal health.

### By Distribution Channel: Veterinary Clinics (Largest) vs. Online Pharmacies (Fastest-Growing)

In the India animal vaccines market, Veterinary Clinics dominate the distribution channel segment, capturing a significant share among various distribution methods. This is primarily due to their established relationships with pet owners and livestock farmers, allowing close monitoring of animal health and vaccination requirements. Conversely, Online Pharmacies are emerging as the fastest-growing segment, fueled by the increasing trend of e-commerce and digital health solutions. The convenience of online purchasing and home delivery is rapidly appealing to customers, especially in urban areas, contributing to the overall growth of this channel.

Veterinary Clinics (Dominant) vs. Online Pharmacies (Emerging)

Veterinary Clinics play a dominant role in the distribution of vaccines due to their trusted presence in the community and their hands-on approach to animal care. They provide personalized service, fostering strong relationships with pet owners that encourage compliance with vaccination schedules. In contrast, Online Pharmacies are an emerging force in the market, driven by technological advancements and the growing internet penetration rate. They cater to a tech-savvy clientele looking for convenience and accessibility, offering a diverse range of animal vaccines at competitive prices. The flexibility to order vaccines from the comfort of home is attracting a new demographic, indicating substantial future potential in this channel.

## Competitive Benchmarking

The animal vaccines market in India is characterized by a dynamic competitive landscape, driven by increasing demand for livestock health and the rising prevalence of zoonotic diseases. Key players such as Zoetis (US), Merck Animal Health (US), and Boehringer Ingelheim (DE) are strategically positioned to leverage innovation and regional expansion. These companies focus on developing advanced vaccine formulations and enhancing their distribution networks, which collectively shapes a competitive environment that is both collaborative and competitive, as firms seek to address the diverse needs of the Indian market.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they often set industry standards and drive technological advancements. This competitive structure encourages smaller firms to innovate and differentiate their offerings, thereby enhancing overall market dynamism.
In October Zoetis (US) announced the launch of a new vaccine targeting a prevalent viral disease affecting poultry in India. This strategic move is significant as it not only addresses a critical health issue but also positions Zoetis as a leader in avian health solutions. The introduction of this vaccine is expected to enhance the company's market share and reinforce its commitment to animal health in the region.
In September Merck Animal Health (US) expanded its partnership with local veterinary organizations to improve vaccine accessibility in rural areas. This initiative is crucial as it demonstrates Merck's focus on enhancing distribution channels and ensuring that essential vaccines reach underserved populations. Such partnerships may strengthen Merck's brand loyalty and market penetration in the Indian animal health sector.
In August Boehringer Ingelheim (DE) launched a digital platform aimed at providing veterinarians with real-time data on vaccine efficacy and animal health trends. This innovative approach reflects the growing trend of digitalization within the industry, allowing for better decision-making and improved health outcomes. By integrating technology into its operations, Boehringer Ingelheim is likely to enhance its competitive edge and foster stronger relationships with veterinary professionals.
As of November current trends in the animal vaccines market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in vaccine development and distribution. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on innovation and technology rather than solely on price. This shift may lead to enhanced supply chain reliability and a more resilient market structure.

## Recent News & Developments

The India Animal Vaccines Market has witnessed significant developments recently, notably with an increasing focus on disease prevention and control among livestock, leading to strong demand for effective vaccines. Companies such as Zoetis, Merck Animal Health, and Hester Biosciences are actively working on innovative vaccine solutions to address the surge in zoonotic diseases. In September 2023, Boehringer Ingelheim announced advancements in their veterinary vaccines that bolster protection against multiple pathogens affecting cattle and poultry, further enhancing their market presence. 

Additionally, in July 2023, Vetoquinol reported new partnerships with local veterinary networks to expand their distribution channels across India, influencing growth rates in the sector. In terms of mergers and acquisitions, India Immunologicals revealed plans for acquiring a smaller firm in August 2023 aimed at enhancing their production capabilities, bolstering their position in the vaccine market. The market is projected to experience significant growth, with a reported valuation expected to reach USD 2 billion by 2025, driven by an increase in livestock populations and heightened awareness regarding animal health in the country.

## Report Scope

| MARKET SIZE 2024 | 575.75(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 619.62(USD Million) |
| MARKET SIZE 2035 | 1291.45(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.62% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Ceva Santé Animale (FR), Heska Corporation (US), Vetoquinol (FR) |
| Segments Covered | Technology, Animal Type, Route of Administration, Distribution Channel |
| Key Market Opportunities | Emerging technologies in vaccine development enhance efficacy and safety in the animal vaccines market. |
| Key Market Dynamics | Rising demand for innovative animal vaccines driven by regulatory changes and increasing awareness of animal health. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What was the market valuation of the animal vaccines market in 2024?**
A: The market valuation of the animal vaccines market was $575.75 Million in 2024.

**Q: What is the projected market valuation for the animal vaccines market by 2035?**
A: The projected market valuation for the animal vaccines market is $1,291.45 Million by 2035.

**Q: What is the expected CAGR for the animal vaccines market during the forecast period 2025 - 2035?**
A: The expected CAGR for the animal vaccines market during the forecast period 2025 - 2035 is 7.62%.

**Q: Which companies are considered key players in the animal vaccines market?**
A: Key players in the animal vaccines market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Virbac, Ceva Santé Animale, Heska Corporation, and Vetoquinol.

**Q: What segment had the highest valuation in the animal vaccines market in 2024?**
A: In 2024, the segment with the highest valuation was Inactivated Vaccines, valued at $230.3 Million.

**Q: How much is the livestock segment projected to be worth by 2035?**
A: The livestock segment is projected to be worth $500.0 Million by 2035.

**Q: What is the valuation range for mRNA Vaccines in the animal vaccines market?**
A: The valuation range for mRNA Vaccines in the animal vaccines market is from $138.125 Million to $301.45 Million.

**Q: Which route of administration is expected to have the highest valuation by 2035?**
A: The Injectable route of administration is expected to have the highest valuation, projected at $550.0 Million by 2035.

**Q: What is the projected valuation for veterinary clinics in the animal vaccines market by 2035?**
A: The projected valuation for veterinary clinics in the animal vaccines market is $681.45 Million by 2035.

**Q: How does the valuation of oral vaccines compare to that of intranasal vaccines in 2024?**
A: In 2024, oral vaccines were valued at $150.0 Million, whereas intranasal vaccines were valued at $90.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-animal-vaccines-market-49187*